Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TT6EMVP)

DTT Name CD85k-Fibronectin interaction (LILRB4-FN1 PPI)
Gene Name LILRB4-FN1 PPI
DTT Type
Clinical trial target
 [1]
UniProt ID
LIRB4_HUMAN-FINC_HUMAN
TTD ID
T63176

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
NGM831 DMAPIXW Aggressive cancer 2A00-2F9Z Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of NGM Biopharma